Our Services
Medical Information
Helpful Resources
Published on: 9/17/2026
If an infection is getting worse after three days on cephalexin, the most common reasons are bacterial resistance, an organism cephalexin does not cover (such as MRSA, a fungal infection, or a virus), or a walled-off abscess that needs drainage rather than pills alone. Other explanations include missed or under-dosed doses, poor absorption, a deeper or spreading infection involving tissue, joint, or bone, and a drug rash being mistaken for worsening illness. Because most bacterial infections start improving within 48 to 72 hours, expanding redness, red streaking, fever, swelling, drainage, or escalating pain are warning signs that call for prompt reevaluation instead of waiting out the full course. There are several important factors and red flags to weigh before your next dose, and they are explained in more detail below.
Since timing matters when an antibiotic is not working, taking a free, instant, online symptom check is a smart next step to organize your symptoms, see which causes fit your situation, and understand whether you need same-day care or a different medication.
Last reviewed for medical accuracy: 09/17/2026
Cephalexin is a commonly prescribed antibiotic in the cephalosporin family. For many skin, ear, throat or urinary infections, doctors often recommend cephalexin 500mg taken every 6–12 hours. Most people start to feel better within 48–72 hours. If your infection seems to be worsening after three days, there are several possible explanations.
For non-urgent guidance, you might consider a free, online symptom check, using the doctor approved Ubie Symptom Checker.
If you experience anything that feels life-threatening or seriously concerning—such as difficulty breathing, chest pain, sudden confusion, or signs of sepsis (very high fever, rapid heartbeat, low blood pressure)—go to the nearest emergency department or call your local emergency number.
This information is based on current medical guidelines and credible sources, but it cannot replace personalized medical advice. If your infection isn’t improving, always speak to a doctor for tailored care and to prevent complications.
(References)
* Selwyn S, Bakhtiar M. Penicillin-resistant gonococci. Br Med J. 1977 Jul 9;2(6079):118-9. doi: 10.1136/bmj.2.6079.118-a. PMID: 406004; PMCID: PMC1630963.
* Hyslop DL, Bischoff W. Loracarbef (LY163892) versus cefaclor and norfloxacin in the treatment of uncomplicated pyelonephritis. Am J Med. 1992 Jun 22;92(6A):86S-94S. doi: 10.1016/0002-9343(92)90614-h. PMID: 1621752.
* Devi M, Dutta JB, Rajkhowa S, Kalita D, Saikia GK, Das BC, Hazarika RA, Mahato G. Prevalence of multiple drug resistant Streptococcus suis in and around Guwahati, India. Vet World. 2017 May;10(5):556-561. doi: 10.14202/vetworld.2017.556-561. Epub 2017 May 28. PMID: 28620262; PMCID: PMC5465772.
* Ozenoxacin 1% cream (Xepi) for impetigo. Med Lett Drugs Ther. 2019 Apr 22;61(1570):63-64. PMID: 31169810.
* Turner A, Schubert H, Puddy EF, Sealey JE, Gould VC, Cogan TA, Avison MB, Reyher KK. Factors influencing the detection of antibacterial-resistant Escherichia coli in faecal samples from individual cattle. J Appl Microbiol. 2022 Apr;132(4):2633-2641. doi: 10.1111/jam.15419. Epub 2021 Dec 28. PMID: 34923720.
* Verkaik NJ, Yalcin YC, Bax HI, Constantinescu AA, Brugts JJ, Manintveld OC, Birim O, Croughs PD, Bogers AJJC, Caliskan K. Single-Center Experience With Protocolized Treatment of Left Ventricular Assist Device Infections. Front Med (Lausanne). 2022;9:835765. doi: 10.3389/fmed.2022.835765. Epub 2022 May 24. PMID: 35685416; PMCID: PMC9171101.
* Khan A, Jabeen H, Ahmad T, Rehman NU, Khan SS, Shareef H, Sarwar R, Yahya S, Hussain N, Uddin J, Hussain J, Al-Harrasi A. Comparative efficacy of cephradine-loaded silver and gold nanoparticles against resistant human pathogens. Artif Cells Nanomed Biotechnol. 2022 Dec;50(1):312-321. doi: 10.1080/21691401.2022.2144340. PMID: 36380462.
* Treatment of common respiratory tract infections. Med Lett Drugs Ther. 2023 Apr 17;65(1674):57-62. doi: 10.58347/tml.2023.1674a. PMID: 37039613.
* Lloyd A, Grey J, Fronczek C, Durkin H, Marr K. Cefdinir vs cephalexin for the treatment of urinary tract infections: A retrospective evaluation. Am J Health Syst Pharm. 2024 May 24;81(Suppl 2):S55-S60. doi: 10.1093/ajhp/zxae026. PMID: 38349523.
* Mitzner TM, Eid KM, Hughson DM, Jameson AP, Dumkow LE. Cefdinir Versus Cephalexin for the Treatment of Uncomplicated Urinary Tract Infections. Open Forum Infect Dis. 2025 Oct;12(10):ofaf501. doi: 10.1093/ofid/ofaf501. Epub 2025 Oct 23. PMID: 41141459; PMCID: PMC12548368.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.